the UK NHS , whose "chip-in-a-pill" collaboration with Otsuka was accepted by Proteus Health yesterday , has urged Proteus Health to follow suit and "think about the way they deliver care", adding "it's not sustainable to keep going the way we are". The company's sensor pills enable patients to check the pill is being correctly metabolised, and check they are keeping to their regimen, the latter issue afflicting up to 50% of prescription medication in the US .
Proteus Health, whose "chip-in-a-pill" collaboration with Otsuka was accepted by the US FDA earlier this month, has urged the UK NHS to follow suit and "think about the way they deliver care", adding "it's not sustainable to keep going the way we are". The company's sensor pills enable patients to check the pill is being correctly metabolised, and check they are keeping to their regimen, the latter issue afflicting up to 50% of prescription medication in the UK.